Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.
about
The Epigenetic Control of Hepatitis B Virus Modulates the Outcome of InfectionHepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesMolecular mechanism of hepatitis B virus-induced hepatocarcinogenesisNovel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and developmentManagement of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalTargeted therapy for hepatocellular carcinoma: novel agents on the horizonThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateRole of epigenetic aberrations in the development and progression of human hepatocellular carcinomaLinking metabolism and epigenetic regulation in development of hepatocellular carcinomaThe role of suppressors of cytokine signalling in human neoplasmsGene expression and hepatitis C virus infectionEpigenetic impact of infection on carcinogenesis: mechanisms and applicationsZebrafish as an In Vivo Model to Assess Epigenetic Effects of Ionizing RadiationEpigenetic regulation in hepatocellular carcinoma requires long noncoding RNAsMolecular classification and novel targets in hepatocellular carcinoma: recent advancementsMitophagy mechanisms and role in human diseasesDNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosisEpigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma.Nix Nought Nothing: fairy tale or real deal.Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1.Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinomaInsight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-reviewEpigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta.Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous mice.Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignanciesHigh-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma.Identification of novel methylation markers in hepatocellular carcinoma using a methylation arrayEpigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions.Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivoCLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinomaAlcohol, DNA methylation, and cancerS-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer.An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma.Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancerHypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma.Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.
P2860
Q26771469-7A2C0A7B-05AE-4547-AF19-75F7F9F9670BQ26772317-60F7FBB2-AEDC-427F-BFE3-AC0681AB45C8Q26823512-D84068B6-1852-405F-9F43-424CBED36A74Q26851211-650CE4B1-0982-4DC3-8868-65E145DA10E8Q26853543-09C231DC-623A-44A6-86BD-9FFD53C00F45Q27002288-DD693F8D-EA0E-4C84-816F-26B92EFBDF7AQ27003050-22CCD313-8F63-4C07-8A7B-6C8110CD23BFQ27023524-5CBC330F-50B0-4A90-B442-4E37712E45F1Q27023744-337E14C4-91F4-4468-816C-7225E0D2596FQ27026783-FE10953D-2030-45E7-BEA9-23B5B66664D9Q27488345-E3D9D185-0C41-48CB-AFBD-B2EF8A77BE1FQ28066519-55B5A465-6ABA-49F6-A80D-DD565E53E8D7Q28077714-EF7953D3-D081-4980-9D9A-A70E4432E447Q28084553-CA8EEF67-4473-430E-B2B3-96CC66AB75BAQ28383646-4C190C9D-5260-4569-B67B-7BB3D83A556EQ28390998-B370140A-02D4-46DD-81AD-AD48E66FEE59Q28484901-AA8205AC-1CF5-4052-BF05-76AEBF77E4ACQ30157007-300AF42D-72C8-4AA3-BA90-500445AACE47Q30393953-0F60E785-CBEA-49B5-9C31-C8872BBF4C78Q31130829-08B68FD2-D31A-4953-B00F-BC09AFBB8BF6Q33543795-21CD8840-003F-41ED-87C8-97F74D18A871Q33632373-9CEDC9EC-494B-48DB-B4F0-BCE6E1BFE3D6Q33731768-C217B83A-8CC0-470E-9CC0-AD361DE4DC83Q33820694-B1E8F0EC-D01F-4FD1-A09C-45450B0888FEQ33821385-FECF73E5-A36F-4913-91BE-B1E7B920E488Q33907989-2810AE12-9932-4248-9BCB-79958EB7EF74Q33966440-4E4CACD9-9F15-4718-8591-9FB1F66CD88BQ34014744-455BABAB-C6EF-4D73-A830-024BD699BF1DQ34028615-9C6BECD7-4AED-4AFB-8AAF-3B0A7EE0B59EQ34078104-DF62DB70-E0D5-471C-BD49-EBA286D1ABAFQ34168643-670AFFA6-E0C0-4E91-8DE8-1B9317F5D483Q34202856-ADBA315C-D884-4279-A898-0DADAC613A15Q34268708-66688CBF-9246-49F1-A33E-5C52F1E05FD6Q34365820-245BBEDE-E39C-4979-9AD3-662382ED9C7DQ34390179-C6B3414F-B6C3-4E5F-A398-F7523B8CE88DQ34394796-27A2B417-9D98-41BF-9D76-8EE37DCA5799Q34497012-49A62717-EF75-40EE-BA84-B5803DED7DD2Q34540268-8E396CD1-FBA3-4E49-9D7C-5C5AC5EFF092Q34548742-FA3034E8-0046-40C1-A285-435B62C4402CQ34619389-A91E274E-0D74-482F-B62D-85F6B289AE85
P2860
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mechanistic and prognostic sig ...... uman hepatocellular carcinoma.
@ast
Mechanistic and prognostic sig ...... uman hepatocellular carcinoma.
@en
type
label
Mechanistic and prognostic sig ...... uman hepatocellular carcinoma.
@ast
Mechanistic and prognostic sig ...... uman hepatocellular carcinoma.
@en
prefLabel
Mechanistic and prognostic sig ...... uman hepatocellular carcinoma.
@ast
Mechanistic and prognostic sig ...... uman hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Mechanistic and prognostic sig ...... uman hepatocellular carcinoma.
@en
P2093
Alexis Gorden
Diego F Calvisi
Elizabeth A Conner
Insa Schroeder
Ju-Seog Lee
Miriam Farina
Snorri S Thorgeirsson
Valentina M Factor
P2860
P304
P356
10.1172/JCI31457
P407
P577
2007-09-01T00:00:00Z